Veterinary Drugs Compounding Market, By Drug Class (CNS Agents, Anti-infective Agents, Hormones and Substitutes, Anti-inflammatory Agents, Others), By Animal Type (Companion Animals and Livestock Animals), By Formulation (Oral, Injectable, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jun 2024

Code : CMI4796

Pages :224

Formats :

Excel and PDF

Industry : Pharmaceutical

Regional Analysis

Veterinary Drugs Compounding Market Regional Insights

To learn more about this report, Request sample copy

North America has been dominating the global veterinary drugs compounding market with estimated market share of 38.2 % in 2024, owing to high pet ownership and animal healthcare expenditure in the region. Countries like the U.S. have approximately 70 million pet dogs and 74 million pet cats. With such a large pet population, there has been huge demand for top-quality veterinary care. This has led to significant market presence of leading compounding pharmacies and veterinary drug manufacturers in the region. These companies offer a wide variety of compounded medications tailored to specific health conditions and needs of companion animals. Moreover, custom-made dosage forms like transdermal gels and creams are highly preferred over traditional tablets and capsules.

Asia Pacific region presents lucrative opportunities for the market players. Rapidly developing economies like India and China are attracting major international investments. This enables companies to set up manufacturing and distribution networks more efficiently. Growing pet humanization trends and rising disposable incomes are propelling pet adoption. More pet owners are becoming aware of compounded medicines and seeking personalized care for their companion animals. With urbanization and improved access to quality animal healthcare, Asia Pacific is emerging as the fastest growing regional market over the forecast period.